Thursday, June 30, 2016
Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has agreed, subject to certain customary closing conditions (including applicable regulatory approvals), to acquire Clinical Research Management (ClinicalRM). The acquisition will enhance Icon’s ability to access the market for government sponsored research and further enhances Icon’s capabilities in the areas of Vaccines and Infectious Disease.
For years, DrugDev technology has been used directly by leading pharmaceutical companies to improve how their clinical trials are run. In order to advance collaboration and standardization that drive benefits throughout the industry and enable companies to do more trials, the company has launched its CRO Preferred Partner program alongside Charter Member INC Research.
HealthCore will collaborate with PCORnet, the National Patient-Centered Clinical Research Network, on building a sustainable patient-centered outcomes research network to conduct real-world comparative effectiveness research as part of a funding award announced from the Patient-Centered Outcomes Research Institute (PCORI).
BBK Worldwide, a provider of patient recruitment and engagement technologies and services, is partnering with Apptomics, a provider of digital health solutions for patients living with chronic neurological conditions, to develop a new suite of mobile apps for patients, caregivers, physicians and payers.
Daphne Zohar, co-founder and chief executive officer of PureTech Health, a cross-disciplinary biotech company tackling fundamental healthcare needs in disruptive ways, was named the EY Entrepreneur Of The Year 2016 in the New England program. The awards program, which is celebrating its 30th year, recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.
The Abramson Cancer Center at the University of Pennsylvania, The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai announced the establishment of a research consortium focused on accelerating the discovery and development of novel cancer therapeutics and diagnostics for the benefit of patients.
Biomedical Systems, a 40-year-old family-owned clinical trial provider to pharmaceutical, medical device, biotech and CROs, has opened its new Technology and Research Center in St. Louis, near the company’s global headquarters. The state-of-the-art 12,000-square-foot center houses more than 70 software developers, data technicians and business analysts. The center was designed to foster innovation and integration of new technology, in collaboration with customers, to improve efficiencies and ultimately help expedite pharmaceuticals and devices to patients.
The National Institutes of Health and Fundacao Oswaldo Cruz-Fiocruz (Fiocruz), a national scientific research organization linked to the Brazilian Ministry of Health, have begun a multi-country study to evaluate the magnitude of health risks that Zika virus infection poses to pregnant women and their developing fetuses and infants. The study is opening in Puerto Rico and will expand to several locations in Brazil, Colombia and other areas that are experiencing active local transmission of the virus.
Bracket, a clinical trial technology and specialty services provider, will launch its next generation clinical outcomes platform, Bracket eCOA(SM) 6.0, at the 52nd Annual DIA Meeting held on June 26 to 30, 2016 in Philadelphia, Pennsylvania.